Logo
Thursday, 28 March 2024
Wednesday, 19 Feb 2020 04:00 pm

Conduent: Disease Surveillance and Outbreak Management System to Fight Coronavirus

Conduent to Configure and Deploy Coronavirus Tracking Module for Additional Government and Health Organizations Seeking Support

newsImage
 

Conduent Incorporated (Nasdaq: CNDT) announced a version of its disease surveillance and outbreak management platform, Maven®, to securely track, manage and report on cases of the coronavirus, COVID-19, previously known as 2019-nCoV. 

Maven is a software platform developed for organizations, including government agencies, to manage cases of more than 90 communicable diseases. Its flexible design gives organizations the capability to customize disease tracking most prevalent in specific geographies or communities.  

Conduent will host the platform's coronavirus-enabled version of Maven in the company's secure cloud so public health agencies and other organizations can get immediate access to use it. Conduent expects its coronavirus module to be available within the month. Additionally, those with advanced training also can leverage the solution's flexibility to customize the Maven platform on their own to track coronavirus. 

Based on an organization's need, Maven has the capability to track diseases such as influenza, tuberculosis and Ebola. More than 40 organizations are currently using Maven, and some have already taken advantage of the platform's flexibility by configuring it to track the coronavirus's spread within their respective locations. Conduent is also actively facilitating sharing of best practices between clients as they configure their systems to track the outbreak.

"Maven is a valuable tool that organizations can use to identify and follow up on people who may have come into contact with a person infected with a communicable or infectious disease," said Mark Brewer, President, Global Public Sector Solutions, Conduent. "In the absence of a vaccine, tracking and analyzing who is at risk from contact with an infected person is one of the most important methods available to contain diseases like the coronavirus and prevent widespread outbreaks.

"Maven's technology is scalable and can be quickly and easily configured to changing technologies, protocols and geographic locations — all of which are keys to effective disease outbreak response. It is also designed to allow for easier data sharing and integration among health agencies on the front lines of battling the disease." 

Designed with rich contact tracing, outbreak management and detection, state and local health organizations can collaborate to quickly and effectively contain public health crises. Epidemiologists can use Maven's reporting capability to search and analyze the centralized data collected to discover trends and patterns. Maven can also be used to report externally, supporting the need for automatic case reporting to the Centers for Disease Control and Prevention in the United States, the World Health Organization, or local authorities. 


Neha Pandey

Aware of her elements, Neha writes the best articles across industries including electronics & semiconductors, automotive & transportation and food & beverages. Being from the finance background she has the ability to understand the dynamics of every industry and analyze the news updates to form insightful articles. Neha is an energetic person interested in music, travel, and entertainment. Since past 5 years, she written extensively on sectors like technology, finance and healthcare.


Smarter Decisions with Smart News

Smart Market News is committed to getting its readers the latest updates and insights on industries that help in making “smarter” business decisions. With insights and inputs from corporate decision makers, we bring you the stories of adopting innovative solutions and strategies that have been changing the world. Our editorial insights on products, solutions, companies, and adoption of best practices not only help in understanding the markets better, but also prove to be a complete package for your information needs.

Subscribe to our newsletter
Get the latest in your inbox weekly Sign up for the fully charged newsletter
© The News and Media Division of The Insight Partners 2024 | All Rights Reserved | Privacy Policy